Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Arista Networks, Inc. stock logo
ANET
Arista Networks
$80.11
-0.2%
$106.38
$60.08
$133.58
$101.02B1.088.69 million shs6.96 million shs
NVIDIA Co. stock logo
NVDA
NVIDIA
$115.58
-0.1%
$129.71
$75.61
$153.13
$2.82T1.77322.71 million shs297.67 million shs
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$680.61
-1.3%
$695.93
$642.00
$1,211.20
$74.41B0.27620,959 shs863,695 shs
7 Top Nuclear Stocks To Buy Now Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Arista Networks, Inc. stock logo
ANET
Arista Networks
-0.29%-5.01%-31.43%-28.73%+14.11%
NVIDIA Co. stock logo
NVDA
NVIDIA
-0.14%+4.53%-12.97%-13.91%+27.17%
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
-1.29%-2.55%+2.28%-6.93%-29.50%
Remove Ads
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Arista Networks, Inc. stock logo
ANET
Arista Networks
4.8857 of 5 stars
4.43.00.03.63.52.52.5
NVIDIA Co. stock logo
NVDA
NVIDIA
4.899 of 5 stars
4.54.01.73.02.72.51.9
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
4.6551 of 5 stars
4.43.01.72.32.01.71.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Arista Networks, Inc. stock logo
ANET
Arista Networks
2.80
Moderate Buy$114.0042.31% Upside
NVIDIA Co. stock logo
NVDA
NVIDIA
2.98
Moderate Buy$171.6948.54% Upside
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
2.76
Moderate Buy$973.1342.98% Upside

Current Analyst Ratings Breakdown

Latest NVDA, REGN, and ANET Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/5/2025
Arista Networks, Inc. stock logo
ANET
Arista Networks
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy$112.00 ➝ $115.00
3/3/2025
Arista Networks, Inc. stock logo
ANET
Arista Networks
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
3/3/2025
Arista Networks, Inc. stock logo
ANET
Arista Networks
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight
3/3/2025
Arista Networks, Inc. stock logo
ANET
Arista Networks
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight
2/28/2025
NVIDIA Co. stock logo
NVDA
NVIDIA
DZ Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Strong-Buy
2/27/2025
NVIDIA Co. stock logo
NVDA
NVIDIA
DA Davidson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$135.00 ➝ $135.00
2/27/2025
NVIDIA Co. stock logo
NVDA
NVIDIA
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$200.00 ➝ $200.00
2/27/2025
NVIDIA Co. stock logo
NVDA
NVIDIA
Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$190.00 ➝ $190.00
2/27/2025
NVIDIA Co. stock logo
NVDA
NVIDIA
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$204.00 ➝ $205.00
2/27/2025
NVIDIA Co. stock logo
NVDA
NVIDIA
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$160.00 ➝ $160.00
2/27/2025
NVIDIA Co. stock logo
NVDA
NVIDIA
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$190.00 ➝ $200.00
(Data available from 3/14/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Arista Networks, Inc. stock logo
ANET
Arista Networks
$7.00B14.43$1.70 per share47.08$7.93 per share10.10
NVIDIA Co. stock logo
NVDA
NVIDIA
$130.50B21.61$1.02 per share112.93$1.72 per share67.20
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$14.20B5.24$44.69 per share15.23$268.50 per share2.53
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Arista Networks, Inc. stock logo
ANET
Arista Networks
$2.85B$2.2236.0831.053.1040.72%29.91%21.67%5/6/2025 (Estimated)
NVIDIA Co. stock logo
NVDA
NVIDIA
$29.76B$2.9445.4929.041.7655.69%114.83%76.61%5/28/2025 (Estimated)
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$4.41B$38.2817.7817.902.3431.07%16.32%12.76%5/1/2025 (Estimated)

Latest NVDA, REGN, and ANET Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
2/26/2025Q4 2025
NVIDIA Co. stock logo
NVDA
NVIDIA
$0.84$0.89+$0.05$0.89$38.16 billion$39.33 billion
2/18/2025Q4 2024
Arista Networks, Inc. stock logo
ANET
Arista Networks
$0.57$0.59+$0.02$0.62$1.90 billion$1.93 billion
2/4/2025Q4 24
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$11.21$12.07+$0.86$8.06$3.76 billion$3.79 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Arista Networks, Inc. stock logo
ANET
Arista Networks
N/AN/AN/AN/AN/A
NVIDIA Co. stock logo
NVDA
NVIDIA
$0.040.03%+33.42%1.36%N/A
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$0.880.13%N/A2.30%N/A

Latest NVDA, REGN, and ANET Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/26/2025
NVIDIA Co. stock logo
NVDA
NVIDIA
quarterly$0.010.03%3/12/20253/12/20254/2/2025
2/20/2025
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
quarterly$0.880.53%2/20/20252/20/20253/20/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Arista Networks, Inc. stock logo
ANET
Arista Networks
N/A
4.36
3.69
NVIDIA Co. stock logo
NVDA
NVIDIA
0.13
4.10
3.64
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
0.09
4.73
3.95

Institutional Ownership

CompanyInstitutional Ownership
Arista Networks, Inc. stock logo
ANET
Arista Networks
82.47%
NVIDIA Co. stock logo
NVDA
NVIDIA
65.27%
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
83.31%

Insider Ownership

CompanyInsider Ownership
Arista Networks, Inc. stock logo
ANET
Arista Networks
3.54%
NVIDIA Co. stock logo
NVDA
NVIDIA
4.23%
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
7.48%
CompanyEmployeesShares OutstandingFree FloatOptionable
Arista Networks, Inc. stock logo
ANET
Arista Networks
4,4121.26 billion1.22 billionOptionable
NVIDIA Co. stock logo
NVDA
NVIDIA
29,60024.40 billion23.45 billionOptionable
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
11,900109.33 million101.15 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Arista Networks stock logo

Arista Networks NYSE:ANET

$80.10 -0.15 (-0.18%)
Closing price 03/13/2025 03:59 PM Eastern
Extended Trading
$81.95 +1.85 (+2.30%)
As of 08:04 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Arista Networks, Inc. engages in the development, marketing, and sale of data-driven, client to cloud networking solutions for data center, campus, and routing environments in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. Its cloud networking solutions consist of Extensible Operating System (EOS), a publish-subscribe state-sharing networking operating system offered in combination with a set of network applications. The company offers data center and cloud networking systems, including newer artificial intelligence (AI) ethernet switching platforms; campus wired and wireless products, and routing systems addressing Core Routing, Edge Routing, Data Center Interconnect (DCI), Multi-cloud and Wide Area Networking (WAN) use cases; and a suite of value-add software solutions that leverage EOS to provide end-to-end orchestration, automation, analytics, network monitoring, and security. It also provides post contract customer support services, such as technical support, hardware repair and replacement parts beyond standard warranty, bug fixes, patches, and upgrade services. The company serves a range of industries comprising internet companies, service providers, financial services organizations, government agencies, media and entertainment companies, telecommunication service providers, and others. It markets and sells its products through distributors, system integrators, value-added resellers, and original equipment manufacturer partners, as well as through its direct sales force. The company was formerly known as Arastra, Inc. and changed its name to Arista Networks, Inc. in October 2008. Arista Networks, Inc. was incorporated in 2004 and is headquartered in Santa Clara, California.

NVIDIA stock logo

NVIDIA NASDAQ:NVDA

$115.58 -0.16 (-0.14%)
Closing price 03/13/2025 04:00 PM Eastern
Extended Trading
$118.45 +2.87 (+2.48%)
As of 08:05 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NVIDIA Corporation provides graphics and compute and networking solutions in the United States, Taiwan, China, Hong Kong, and internationally. The Graphics segment offers GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, and solutions for gaming platforms; Quadro/NVIDIA RTX GPUs for enterprise workstation graphics; virtual GPU or vGPU software for cloud-based visual and virtual computing; automotive platforms for infotainment systems; and Omniverse software for building and operating metaverse and 3D internet applications. The Compute & Networking segment comprises Data Center computing platforms and end-to-end networking platforms, including Quantum for InfiniBand and Spectrum for Ethernet; NVIDIA DRIVE automated-driving platform and automotive development agreements; Jetson robotics and other embedded platforms; NVIDIA AI Enterprise and other software; and DGX Cloud software and services. The company's products are used in gaming, professional visualization, data center, and automotive markets. It sells its products to original equipment manufacturers, original device manufacturers, system integrators and distributors, independent software vendors, cloud service providers, consumer internet companies, add-in board manufacturers, distributors, automotive manufacturers and tier-1 automotive suppliers, and other ecosystem participants. NVIDIA Corporation was incorporated in 1993 and is headquartered in Santa Clara, California.

Regeneron Pharmaceuticals stock logo

Regeneron Pharmaceuticals NASDAQ:REGN

$680.61 -8.89 (-1.29%)
Closing price 03/13/2025 04:00 PM Eastern
Extended Trading
$683.92 +3.31 (+0.49%)
As of 08:02 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; diabetic retinopathy; neovascular glaucoma; and retinopathy of prematurity. It also provides Dupixent injection to treat atopic dermatitis and asthma in adults and pediatrics; Libtayo injection to treat metastatic or locally advanced cutaneous squamous cell carcinoma; Praluent injection for heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in adults; REGEN-COV for covid-19; and Kevzara solution for treating rheumatoid arthritis in adults. In addition, the company offers Inmazeb injection for infection caused by Zaire ebolavirus; ARCALYST injection for cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome; and ZALTRAP injection for intravenous infusion to treat metastatic colorectal cancer; and develops product candidates for treating patients with eye, allergic and inflammatory, cardiovascular and metabolic, infectious, and rare diseases; and cancer, pain, and hematologic conditions. It has collaboration with Mammoth Biosciences, Inc. to research, develop and commercialize in vivo CRISPR-based gene editing therapies for multiple tissues and cell types. The company was incorporated in 1988 and is headquartered in Tarrytown, New York.